Appearances

• Interactive Cases on Changing the Paradigm of CV Prevention: Using Lipid Targets, the New Hypertension Guidelines, Novel Glucose-Lowering Therapies, and Coronary Calcium
• What Next? Considerations for SGLT2/GLP1
• Prevention Beyond the Guidelines: What to Do Next
• Gaps in the 2018 Cholesterol Guidelines: The Great Debate(s)
• SecondaryPrevention: SGLT2i